Latest Breaking News On - வளர்ப்பு நகரம் - Page 12 : comparemela.com
New Phase 3 Data Support the Sustained, Long-Acting Efficacy of Lenacapavir, Gilead s Investigational HIV-1 Capsid Inhibitor
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
New Phase 3 Data Support the Sustained, Long-Acting Efficacy of Lenacapavir, Gilead s Investigational HIV-1 Capsid Inhibitor
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
Four-Year Biktarvy® Data Presented at IAS 2021 Demonstrate High Efficacy and Durable Viral Suppression in Treatment-Naïve Adults
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
Published July 16, 2021, 11:45 AM
Sandiganbayan
The Sandiganbayan has dismissed the civil case filed 34 years ago against the late former Ferdinand E. Marcos, his wife Imelda R. Marcos, and the late businessmen Ricardo C. Silverio and Pablo P. Carlos Jr. in connection with their alleged ill-gotten wealth.
The case, denominated as Civil Case No. 0011, was filed by the Presidential Commission on Good Government (PCGG) on July 22, 1987 for reconveyance, reversion, accounting, restitution and damages.
The Marcoses, Silverio and Carlos were accused of abuse of right and power, unjust enrichment, and breach of public trust.
Former President Marcos died in 1989; Carlos in 1998, and Silverio in 2016.
Gilead Sciences to Release Second Quarter 2021 Financial Results on Thursday, July 29, 2021
Gilead Sciences, Inc. announced today that its second quarter 2021 financial results will be released on Thursday, July 29, after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s second quarter 2021 financial results and will provide a business update. A live webcast will be available on the investor relations page of and will be archived on … Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2021 financial results will be released on Thursday, July 29, after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s second quarter 2021 financial results and will provide a business update.